![Godelieve Verplancke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Godelieve Verplancke
Directeur/Membre du Conseil chez MATERIALISE NV
Fortune : - $ au 30/06/2024
Profil
Dr. Godelieve Verplancke is an Independent Director at Materialise NV.
She is on the Board of Directors at Materialise NV and Fondation contre le Cancer.
Dr. Verplancke was previously employed as an Independent Non-Executive Director by MDxHealth SA, an Independent Director by Quest for Growth NV, a Managing Director by Qaly, a Managing Director by Qaly-Co BV, a Managing Director by BRISTOL MYERS SQUIBB BELGIUM BV, and a Managing Director by Merck & Co., Inc. She also served on the board at Euronext Brussels SA/NV, Imelda Hospital and Stichting Tegen Kanker.
She received her graduate degree from the University of Antwerp, an MBA from the University of Antwerp and a doctorate degree from Katholieke Universiteit Leuven.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
MDXHEALTH S.A.
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 30/06/2024 |
Postes actifs de Godelieve Verplancke
Sociétés | Poste | Début |
---|---|---|
MATERIALISE NV | Directeur/Membre du Conseil | 09/06/2015 |
Fondation contre le Cancer | Directeur/Membre du Conseil | - |
Anciens postes connus de Godelieve Verplancke
Sociétés | Poste | Fin |
---|---|---|
MDXHEALTH SA | Directeur/Membre du Conseil | 08/07/2024 |
Qaly | Directeur Général | 01/01/2020 |
Qaly-Co BV | Fondateur | 01/01/2020 |
Bristol-Myers Squibb Belgium SA
![]() Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Corporate Officer/Principal | 01/01/2012 |
Stichting Tegen Kanker | Directeur/Membre du Conseil | - |
Formation de Godelieve Verplancke
Katholieke Universiteit Leuven | Doctorate Degree |
University of Antwerp | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
MERCK & CO., INC. | Health Technology |
MDXHEALTH SA | Health Technology |
MATERIALISE NV | Technology Services |
Entreprise privées | 8 |
---|---|
Euronext Brussels SA/NV
![]() Euronext Brussels SA/NV Investment Banks/BrokersFinance Euronext Brussels SA/NV operates a stock exchange. It provides services for regulated stock and derivatives markets in Belgium. The company also offers services, such as facilitating public offerings, providing trading facilities for cash & derivatives products and supplying market data. Euronext Brussels was founded in 1801 and is headquartered in Brussels, Belgium. | Finance |
Quest for Growth NV
![]() Quest for Growth NV Investment ManagersFinance Quest for Growth NV, a fund traded on Euronext Brussels, has a diversified portfolio which is invested in growth companies listed on European stock exchanges, in European unquoted companies and in venture capital funds. It targets companies operating in the fields of healthcare, healthy living, well-being, human development, smart industries, digitalisation and clean technology & sustainable chemistry. It provides financing for growth stage capital requirements. It also makes co-investments. | Finance |
Bristol-Myers Squibb Belgium SA
![]() Bristol-Myers Squibb Belgium SA Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb Belgium SA develops, manufactures and distributes medicines. The company is based in Watermael-Boitsfor, Belgium. The CEO of the Belgian company is Paul Lacante. | Health Technology |
Stichting Tegen Kanker | Miscellaneous |
Qaly | |
Imelda Hospital | |
Fondation contre le Cancer | Miscellaneous |
Qaly-Co BV |